Le Lézard7h
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIRtm (sotatercept-csrk) Early and Move to Final Analysis
Merck , known as MSD outside of the United States and Canada, announced today the Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk) versus placebo (both in combination with background ...
There's a Surprising Reason You Should Reconsider Eating Leftover Rice
If you left a pot of rice out overnight, you might want to reconsider eating it the next day. Rice contains a bacterium ...
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposium Eight abstracts discussing data and clinical experience associated with MIPLYFFA accepted for poster ...